CC
ALNY icon

Corton Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Corton Capital’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-946
Closed -$223K – 176
2024
Q4 		$223K Buy
+946
New +$249K 0.13% 225
2024
Q2 		– Sell
-3,004
Closed -$449K – 490
2024
Q1 		$449K Sell
3,004
-1,823
-38% -$304K 0.17% 157
2023
Q4 		$924K Buy
4,827
+3,489
+261% +$594K 0.29% 56
2023
Q3 		$237K Sell
1,338
-1,553
-54% -$296K 0.12% 258
2023
Q2 		$549K Buy
+2,891
New +$573K 0.26% 87

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return